Assemblée législative de l'Ontario

Letter: E

• Elliott, Hon. C. (PC, Newmarket–Aurora)

  • Addictions services
    • access to, E13
    • government strategy, E13–E14
  • Advertising
    • jurisdiction over, E52
  • Alternate-level-of-care (ALC), E6, E62
  • Ambulance services
    • land ambulances
      • government funding, E43
  • Auditor General of Ontario
    • Reports
      • 2017 Annual Report: Ch. 3.10 - Public Health: Chronic Disease Prevention, E49–E50
  • Cancer Care Ontario
    • general remarks, E31–E32
  • Consumption and treatment services
    • general remarks, E14
    • government funding, E34
    • review and consultation process, E14
  • Consumption and treatment services - sites
    • geographic distribution, E14
    • licensing criteria, E33
  • Crisis services
    • mobile crisis teams, E14
  • Dental care
    • community access points, E23, E64
    • via hospital and primary care, E16, E64
  • Government expenditures
    • budget allocation
      • health and long-term care, E5
  • Health care - administration
    • supply chain management, E8, E20, E28
  • Health care services - delivery
    • coordination of care, E6, E18, E41, E65
  • Health care system
    • patient navigation of, E5–E6
  • Health care system - digital reforms, E6, E12
    • Digital Health Playbook, E65–E66
    • funding allocation
      • platform development and updating, E46, E69
    • general remarks, E46, E65
  • Health care system - reform
    • administrative centralization
      • general remarks, E7
    • consultation process, E19
    • cost, E12, E69
    • general remarks, E6–E7, E16–E17, E40
    • projected cost savings
      • annual targets, E63
      • calculation of, E9
  • Health professionals
    • scopes of practice
      • expansion of, E16
  • Home and community care
    • care coordinators, E65
    • general remarks, E15–E16, E41
    • government funding, E15, E41
  • Hospital funding
    • base funding, E15
    • capital projects, E15, E59
    • surge funding, E15
  • Hospital services
    • emergency and acute care
      • wait times, E5
    • transition out of care
      • cross-agency communication, E5
      • Southlake@Home program, E6, E62
  • Hospitals
    • capacity and overcrowding
      • beds, new, E15, E59
      • general remarks, E5
      • government strategy, E59
      • patient flow, E62
  • Long-term care
    • government funding, E34
    • occupancy and wait-lists, E14, E34
  • Long-term-care beds
    • new
      • development timeline, E14
      • general remarks, E34, E39
      • vs. spaces, E40
    • upgraded, E14, E34, E39
  • Long-term-care facilities
    • licensing
      • temporary emergency licences, E15
    • new, E14–E15
  • Mental health and addictions
    • sector consultations, E47
  • Mental Health and Addictions Centre of Excellence
    • cost of development, E32
    • mandate and role, E32–E33
  • Mental health and addictions services
    • access to, E13, E47
    • government strategy, E13–E14
    • service delivery
      • general remarks, E47
    • wait times, E13
  • Mental health and addictions services - funding, E13, E27
    • allocation, E13–E14, E31
    • children and youth, E31
      • school vs. community allocation, E31
    • distribution, E27, E31
    • general remarks, E13, E27
  • Mental health conditions
    • general remarks, E13
  • Ministry of Health and Long-Term Care
    • estimates (2019-2020), E5–E20, E22–E23, E25, E27–E28, E31–E34, E39–E41, E43, E45–E47, E49–E50, E52, E59, E62–E66, E68–E69, E71
  • OHIP+: Children and Youth Pharmacare Program
    • eligibility, E10
    • second payer model, E10
  • Ontario Drug Benefit Program
    • formulary
      • new drug coverage, E71
  • Ontario Health
    • agencies transferred under, E7
    • board of directors
      • qualifications and selection of, E8
    • implementation process
      • timeline, E8, E17
    • performance measurement
      • reporting on, E17
    • role and responsibilities, E7–E8
  • Ontario health teams
    • and care coordinators, E65
    • caseload, E19
    • and doctors, E7
    • funding allocation
      • across services, E45, E65
    • general remarks, E6–E7, E20
    • governance structure, E65
    • implementation process
      • applications, E7, E41
      • timeline, E7
    • number of, E19
    • patient experience, E19
    • performance measurement, E7
    • services
      • division of providers, E45
  • Opioid addiction
    • cost to health care system, E34
  • Opioids
    • manufacturer liability lawsuits
      • general remarks, E34
  • Palliative care
    • home vs. community
      • availability, E41
  • People's Health Care Act, 2019 (Bill 74)
    • proclamation of, E17
  • Personal health information
    • patient access, E68
  • Prescription drugs
    • coverage through Trillium Drug Program, E11
  • Public health
    • funding
      • provincial-municipal cost-sharing, E8, E43
  • Public health - programs
    • dental care
      • for senior citizens, E12, E16, E23, E50, E64
  • Public health units
    • coordination between, E50
    • governance, E8–E9
    • restructuring
      • amalgamation, E8–E9, E12, E50
  • Smoke-Free Ontario Act, 2017, S.O. 2017, c. 26, Sched. 3
    • general remarks, E25
  • Trillium Drug Program
    • as backstop for coverage gaps, E11
  • Vaping
    • pulmonary illness due to
      • reporting requirements, E52
  • Vaping and youth
    • prevalence, E52
  • Vaping products
    • e-juice
      • nicotine content, E52
    • marketing and display
      • restrictions, E52